Skip to main content
Premium Trial:

Request an Annual Quote

OpGen Closes $5 Million Series B Financing

NEW YORK, Jan. 24 (GenomeWeb News) - OpGen said today that it has closed a series B financing round, raising a total of $5 million.

 

Investors in the financing included Mason Wells Biomedical Fund, Stonehenge Capital, the State of Wisconsin Investment Board, and the Wisconsin Alumni Research Foundation, according to the company.

 

OpGen said that the proceeds of the financing will be used to expand its marketing and sales infrastructure, conduct commercial service collaborations and contracts, and accelerate commercialization of its optical mapping genome comparison technology.

The Scan

Mosquitos Genetically Modified to Prevent Malaria Spread

A gene drive approach could be used to render mosquitos unable to spread malaria, researchers report in Science Advances.

Gut Microbiomes Allow Bears to Grow to Similar Sizes Despite Differing Diets

Researchers in Scientific Reports find that the makeup of brown bears' gut microbiomes allows them to reach similar sizes even when feasting on different foods.

Finding Safe Harbor in the Human Genome

In Genome Biology, researchers present a new approach to identify genomic safe harbors where transgenes can be expressed without affecting host cell function.

New Data Point to Nuanced Relationship Between Major Depression, Bipolar Disorder

Lund University researchers in JAMA Psychiatry uncover overlapping genetic liabilities for major depression and bipolar disorder.